Related Experiment Videos
Management of elevated intracranial pressure
1University of Michigan Hospitals, College of Pharmacy, University of Michigan, Ann Arbor 48109-0008.
Summary
High-dose barbiturates, like pentobarbital, can improve survival rates in patients with elevated intracranial pressure (ICP) that is refractory to conventional treatments. Intensive monitoring and aggressive management are crucial for treating this condition.
Area of Science:
- Neurology
- Critical Care Medicine
Background:
- Elevated intracranial pressure (ICP) is a critical condition associated with severe head injuries, brain tumors, and stroke.
- Symptoms of elevated ICP can be subtle and difficult to differentiate from other neurological conditions.
Purpose of the Study:
- To review the pathophysiology, clinical manifestations, monitoring, and management of elevated ICP.
- To discuss the detailed use of barbiturate coma for refractory ICP.
Main Methods:
- Review of existing literature on ICP management.
- Discussion of ICP monitoring techniques (e.g., intraventricular catheter, Camino fiber optic system).
- Analysis of conventional treatments (physiologic and pharmacologic) and high-dose barbiturate therapy (pentobarbital).
Main Results:
- ICP monitoring is vital for early detection before clinical signs appear.
- Conventional treatments include CSF removal, fluid restriction, hyperventilation, sedation, and diuretics.
- High-dose barbiturates, particularly pentobarbital, show improved survival rates in refractory ICP cases when combined with conventional therapies.
Conclusions:
- Aggressive therapy and intensive monitoring are essential for managing elevated ICP.
- Barbiturate coma, especially with pentobarbital, offers a survival benefit for patients with refractory ICP.
- Close monitoring of pentobarbital serum concentrations is necessary due to increased clearance during prolonged therapy.